Panel Hep Exchanges track
Metabolic Dysfunction–Associated Steatotic Liver Disease and Concomitant Viral Diseases (Human Immunodeficiency Virus, Hepatitis B Virus)
Sun, Nov 8, 2026 · 9:45–10:45 AM MST Convention Center: Summit 3, The Park @TLM, Hall D, Colorado Convention Center
About this session
Metabolic dysfunction–associated steatotic liver disease (MASLD) increasingly coexists with chronic viral infections, particularly HIV and hepatitis B virus (HBV), creating complex and evolving liver disease phenotypes. This session examines how metabolic dysfunction modifies liver disease progression, fibrosis risk, and clinical outcomes in persons with concomitant HIV and/or HBV infection. The impact of viral infection and antiviral therapies, in turn, influence MASLD natural history.
